Medical experts, patient advocacy groups and high-profile Australians are partnering with GSK Australia to help raise community awareness about invasive meningococcal disease (IMD).
This educational initiative is focused on the signs, symptoms and risk factors of this rare, but potentially devastating disease.
The initiative encourages people to speak to their healthcare professional for more information about meningococcal disease, given the total cases reported to end-September 20221 have already exceeded last year’s total cases for the full year (86 cases as of the end of September 2022; 74 cases in 2021).
The prevalence of IMD declined during 2020-2021 as lockdowns restricted movement and travel.1
But as Australians travel and become more mobile, IMD circulation in the community is increasing, thereby posing a risk to children and adolescents, who are most at risk of the disease.
Infectious diseases paediatrician, Professor Robert Booy, says it is critical for families to know the signs and symptoms of invasive meningococcal disease and that an awareness campaign like this is being rolled out at a perfect time.
“Given we are experiencing an increased level of population movements, I encourage everyone, especially parents of young children, to be talking to their doctor about invasive meningococcal disease,” Professor Booy said.
“It can strike anyone, and we already see an increase in meningococcal disease cases locally and in other countries, like the UK, where the number of cases are nearing pre-pandemic levels.
“Time is of the essence when it comes to minimising the potentially lethal consequences of IMD. We can reduce its impact by educating people about the signs and symptoms to look out for. Confusing the symptoms with a common cold, for example, can put the life of loved ones at risk.”
‘A rare bacterial infection’
IMD is a rare bacterial infection that can progress rapidly.
Early signs and symptoms may be difficult to diagnose as they can easily be mistaken for a common cold, for example, high fever or lethargy.2
Most people who contract meningococcal disease survive, but it’s important that it is diagnosed and treated quickly.5
Up to one in 10 of those infected may die, and up to one in five survivors may develop serious long-term complications, including brain damage, deafness or loss of limbs.3
Meningococcal disease can occur at any age, however, babies (under 2 years of age) and adolescents (15–19 years of age) are most vulnerable to the disease, which is spread by secretions from the nose and throat of a person who is carrying the bacteria. This generally requires close and prolonged contact with a person carrying the bacteria.4
Awareness campaign
GSK Australia has partnered with Australian medical experts, patient advocates and ambassadors to help spread the word on digital media and a dedicated website (knowmeningococcal.com.au).
Campaign ambassador Felicity Harley, an author, host of Body + Soul’s ‘Healthy-ish’ podcasts and wife of an AFL legend Tom Harley, has her own family experience of IMD, as her son Hugo contracted the disease at the age of five weeks old.
“I still vividly remember driving my listless and incredibly ill baby to the hospital and not knowing if he would live. Acting quickly on the first symptoms may have saved his life,” Ms Harley said.
“I cannot imagine where Hugo and our whole family would be now if those signs were missed. I urge all parents to keep meningococcal disease signs and symptoms front of mind.”
Karen Quick, CEO of Meningitis Centre Australia, says she is pleased to see increasing attention to community education around IMD.
“For over 30 years Meningitis Centre Australia has been working hard to make information about IMD easily available to help parents understand the risk their children may face,” Ms Quick said.
“Now more than ever with the increase in IMD cases, parents need to know the signs and symptoms of this disease, so they can act immediately, save lives and avoid potential long-term disability. This information is easily accessible on our website.
“Meningococcal is a devastating disease for Australians and their families. If contracted, it can cause a significant impact on the whole community. It is wonderful to see so many people joining forces to raise awareness, educate the community and encourage people to talk to their healthcare professional.”
For more information about meningococcal, speak to your healthcare professional and visit knowmeningococcal.com.au.
References
- National Notifiable Diseases Surveillance System (NNDSS) data reports.https://www.health.gov.au/resources/collections/nndss-fortnightly-reports#2021, Accessed October 2022.
- The Royal Children’s Hospital Melbourne, Meningococcal Infection, May 2018. https://www.rch.org.au/kidsinfo/fact_sheets/Meningococcal_infection/, Accessed October 2022.
- World Health Organization. Meningococcal meningitis key facts; 28 September 2021. http://www.who.int/en/news-room/fact-sheets/detail/meningococcal-meningitis, Accessed August 2022.
- National Centre for Immunisation Research and Surveillance, Meningococcal Vaccines for Australians, Fact Sheet, 1 July 2020. https://ncirs.org.au/ncirs-fact-sheets-faqs/meningococcal-vaccines-australians, Accessed October 2022.
- Van Deuren M, et al. Clin Microbiol Rev 2000: 13:144–166.
- Lahra M;Communicable Diseases Intelligence;2022;46;1-16.
- NSW Health, Meningococcal disease fact sheet, 8 August 2022. https://www.health.nsw.gov.au/Infectious/factsheets/Pages/meningococcal_disease.aspx, Accessed October 2022.
